Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedAdded a consolidated Locations section listing site locations (California, Kentucky, Maryland, Massachusetts, Ohio, Virginia) to the study page and reorganized location information. The HHS Vulnerability Disclosure link was removed and revision labels updated (v3.3.3 from v3.3.2).SummaryDifference0.6%

- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedRevision line updated to v3.3.2, replacing the previous v3.3.1. This update does not alter study details, eligibility, or outcome data.SummaryDifference0.0%

- Check38 days agoChange DetectedRevision updated from v3.2.0 to v3.3.1; there are no changes to the study details, eligibility criteria, or results sections. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check46 days agoChange Detected- A government funding status notice/banner that warned users about potential delays has been removed from the page. - This banner was a site-wide informational message and does not affect the displayed study details or eligibility criteria.SummaryDifference0.3%

- Check60 days agoChange DetectedNo significant changes detected on the Study Details page. The content remains the same as the existing record for NCT03041688.SummaryDifference0.3%

- Check88 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference2%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.